Biotechnology
Technology
Health
Compugen
$3.349876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.08 (2.45%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Compugen and other stocks, options, ETFs, and crypto commission-free!
About
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. Read More The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Employees
89
Headquarters
Holon, Tel Aviv
Founded
1993
Market Cap
195.11M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
183.61K
High Today
$3.43
Low Today
$3.27
Open Price
$3.27
Volume
29.67K
52 Week High
$4.31
52 Week Low
$2.00
Collections
Biotechnology
Technology
Health
Research And Development
Asia (Non-China)
Asia
Female CEOs
Price Paid on Robinhood
8% Lower
Right Now
52 Week Low
$2.00
Average Price Paid
$3.61
52 Week High
$4.31
Earnings
-$0.19
-$0.13
-$0.06
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.17 per share
Actual
-$0.14 per share